Alcohol Cessation Among Head and Neck Cancer Survivors

Launched by NORTHWELL HEALTH · Oct 4, 2022

Keywords

ClinConnect Summary

HNC survivors (baseline N=138) will be enrolled from Northwell Health and the Brooklyn VA Medical Center, at the 3-month post treatment completion follow-up visit, when alcohol resumption is most likely to occur according to pilot data. The investigators will randomize survivors to either the control condition (AF; n=69) or the text message arm, consisting of: AF plus HNC tailored texts for civilians (n=34) and AF plus HNC tailored texts for Veterans (n=35), for a total of n = 69. The investigators expect 15% attrition over 6 months for a final sample size of N=120. The study's primary outc...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult male or female patients 18 years or older
• • Diagnosed with primary cancer of: pharynx (nasopharynx, oropharynx, hypopharynx), larynx (all subsites), oral cavity (all subsites)
• • Having completed surgical, radiation, and/or chemotherapy treatment;
• • Post-treatment completion status of at least 3 months;
• • Able to communicate and read in English;
• • Possess a telephone with text messaging capability; and
• • Confirmation of alcohol consumption.
• Exclusion Criteria:
• • Non-English speaker
• • Non-drinker
• • Previously enrolled in adaption phase focus-groups to determine intervention content
• • Clinically significant depression, as indicated by an assessment of ≥ 16 on the CES-D 11-item Iowa short form scale